SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-13-015087
Filing Date
2013-03-14
Accepted
2013-03-14 16:20:52
Documents
5
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v338199_10ka.htm 10-K/A 1177212
2 EXHIBIT 31.1 v338199_ex31-1.htm EX-31.1 10088
3 EXHIBIT 31.2 v338199_ex31-2.htm EX-31.2 10191
4 EXHIBIT 32.1 v338199_ex32-1.htm EX-32.1 4178
5 EXHIBIT 32.2 v338199_ex32-2.htm EX-32.2 4064
  Complete submission text file 0001144204-13-015087.txt   1206791
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51462 | Film No.: 13690757
SIC: 2836 Biological Products, (No Diagnostic Substances)